Status:
COMPLETED
Effectiveness of a Health Education Programme for Prevention of Chronic Migraine: A Randomized Clinical Trial
Lead Sponsor:
Universidad de Zaragoza
Collaborating Sponsors:
Universidad San Jorge
Hospital Clínico Universitario Lozano Blesa
Conditions:
Chronic Migraine
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Chronic migraine (CM) is a common and frequent disorder, which has a major impact on the quality of life of migraine sufferers, interfering with physical function, productivity at work, personal life ...
Detailed Description
Design: A randomised, double-blind, controlled clinical trial will be conducted in two parallel groups, in which all patients with migraine chronic are receiving prophylactic drug treatment with Frem...
Eligibility Criteria
Inclusion
- Age range 18-65 years.
- Patients diagnosed with CM following the ICHD-III criteria.
- Patients with migraine onset before the age of 50 years.
- Patients who have been diagnosed with chronic migraine for at least 1 year.
Exclusion
- Women who are pregnant or breastfeeding.
- Women with menstrual migraine.
- Patients with severe or unstable psychiatric pathology that contraindicates the use of drug treatment.
- Allergic patients or those who show sensitivity to components of the drug treatment.
- Patients who refuse to sign the informed consent form or to participate in the study.
- Patients who decide not to continue in the study.
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 26 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04788667
Start Date
April 19 2021
End Date
July 26 2024
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínico Universitario Lozano Blesa
Zaragoza, Spain, 50009